EAM
EULAV Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,000
| Closed | -$3.43M | – | 188 |
|
|
2023
Q1 | $3.43M | Hold |
17,000
| – | – | 0.14% | 133 |
|
|
2022
Q4 | $3.7M | Hold |
17,000
| – | – | 0.16% | 123 |
|
|
2022
Q3 | $3.35M | Hold |
17,000
| – | – | 0.15% | 132 |
|
|
2022
Q2 | $3.64M | Hold |
17,000
| – | – | 0.15% | 141 |
|
|
2022
Q1 | $4.83M | Hold |
17,000
| – | – | 0.14% | 140 |
|
|
2021
Q4 | $6.16M | Hold |
17,000
| – | – | 0.16% | 140 |
|
|
2021
Q3 | $7.02M | Hold |
17,000
| – | – | 0.19% | 131 |
|
|
2021
Q2 | $6.29M | Hold |
17,000
| – | – | 0.17% | 135 |
|
|
2021
Q1 | $4.93M | Buy |
17,000
+1,000
| +6% | +$290K | 0.13% | 155 |
|
|
2020
Q4 | $4M | Buy |
16,000
+10,000
| +167% | +$2.5M | 0.1% | 170 |
|
|
2020
Q3 | $1.36M | Hold |
6,000
| – | – | 0.04% | 220 |
|
|
2020
Q2 | $1.05M | Buy |
+6,000
| New | +$1.05M | 0.03% | 230 |
|